Recent breakthroughs in the field of obesity treatment have generated a novel therapy known as ALLUVI Retatrutide. This compound is a {highlyspecific GLP-1 receptor agonist, formulated to stimulate the effects of natural glucagon-like peptide-1. Retatrutide has shown impressive outcomes in clinical trials, exhibiting significant decreases in body w